Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8–substrate complex
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Histone deacetylases (HDACs)-an enzyme family that deacetylates histones and non-histone proteins-are implicated in human diseases such as cancer, and the first-generation of HDAC inhibitors are now in clinical trials. Here, we report the 2.0 A resolution crystal structure of a catalytically inactive HDAC8 active-site mutant, Tyr306Phe, bound to an acetylated peptidic substrate. The structure clarifies the role of active-site residues in the deacetylation reaction and substrate recognition. Notably, the structure shows the unexpected role of a conserved residue at the active-site rim, Asp 101, in positioning the substrate by directly interacting with the peptidic backbone and imposing a constrained cis-conformation. A similar interaction is observed in a new hydroxamate inhibitor-HDAC8 structure that we also solved. The crucial role of Asp 101 in substrate and inhibitor recognition was confirmed by activity and binding assays of wild-type HDAC8 and Asp101Ala, Tyr306Phe and Asp101Ala/Tyr306Phe mutants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, D94 corresponds to acetyllysine binding residues D101 of hHDAC8 and S568 of hHDAC6 CD2 (refs 17, 30, 31).”
From Histone deacetylase 10 structure and molecular function as a polyamine deacetylase (2017) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In HDAC8, highly conserved D101 accepts hydrogen bonds from the two backbone amide groups flanking the scissile acetyllysine residue.37,38”
From Histone deacetylase 6 structure and molecular basis of catalysis and inhibition (2016) · cites this paper as [37]
In the citing paper
“Crystal structures of human HDAC8, in complex with different inhibitors, have been reported; they revealed a single α/β-domain with a core eight-stranded parallel β-sheet and 11 α-helices.7, 31, 32”
From HDAC8 catalyzes the hydrolysis of long chain fatty acyl lysine (2016) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742 · cited 1×
“Model building was carried out using QUANTA2000 (Accelrys, Cambridge, UK) and refinement with REFMAC (Murshudov et al, 1997).”
MethodPRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,804
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845 · cited 1×
“Acetylation status of the lysine residue at the N-terminal extensions of core histones is controlled by two counteracting enzymes: histone acetyl transferases and histone deacetylases (HDACs; Roth et al, 2001; Marks et al, 2003).”
BackgroundStructures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714 · cited 6×
“The HDAC8 active site (Somoza et al, 2004; Vannini et al, 2004) presents features of both serine and zinc proteases, and contains two His–Asp dyads with both histidine residues supposed to work as a general acid–base catalytic pair, as originally proposed for HDLP and extended to HDAH (Finnin et al, 1999; Nielsen et a…”
BackgroundResultInfluentialThe Sir2 Family of Protein Deacetylases
Blander, G., & Guarente, L. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073651 · Cited by 1,495 · cited 1×
“HDAC11 is distinct from those in classes I and II; therefore, it has been placed in class IV, as class III refers to the unrelated sirtuin deacetylases (Blander & Guarente, 2004).”
BackgroundGregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456 · cited 1×
“Eukaryotic HDACs have been classified into four groups on the basis of phylogenetic analysis (Gregoretti et al, 2004).”
Backgroundp53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage
Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., & Berger, S. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1202 · Cited by 776 · cited 2×
“whereas the substrate has no coumarin group, substituted instead with Leu-Met and corresponding to p53 protein sequence 379–384 (Liu et al, 1999).”
BackgroundFischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00429-4 · Cited by 754 · cited 1×
“The only significant exception is Tyr306, which is histidine in class IIa HDACs (4, 5, 7, 9), which causes a pronounced decrease in catalytic activity on peptidic substrates (Fischle et al, 2002).”
BackgroundStructural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Gallinari, P., Marco, S. D., Jones, P., Pallaoro, M., & Steinkühler, C. (2007) · Cell Research · doi:10.1038/sj.cr.7310149 · Cited by 678 · cited 1×
“As these processes are modulated during malignant transformation, HDAC inhibitors are being developed as antineoplastic drugs (Gallinari et al, 2007), and vorinostat was recently approved by the Food and Drug Administration for the treatment of cutaneous T-cell lymphoma.”
BackgroundSelf-citation
Cited by
Items 101–200 of 284
Discovery of a Selective Series of Inhibitors of Plasmodium falciparum HDACs
Ontoria, J. M., Paonessa, G., Ponzi, S., Ferrigno, F., Nizi, E., Biancofiore, I., Malancona, S., Graziani, R., Roberts, D., Willis, P. A., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00468 · Cited by 45
Display of B. pumilus chitinase on the surface of B. subtilis spore as a potential biopesticide
Rostami, A., Hinc, K., Goshadrou, F., Shali, A., Bayat, M., Hassanzadeh, M., Amanlou, M., Eslahi, N., & Ahmadian, G. (2017) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2017.05.008 · Cited by 51
Shinsky, S. A., & Christianson, D. W. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00079 · Cited by 41
Abdel-Atty, M. M., Farag, N. A., Kassab, S. E., Serya, R. A. T., & Abouzid, K. A. M. (2014) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2014.08.006 · Cited by 42
Amin, S. A., Adhikari, N., & Jha, T. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0130 · Cited by 45
“The carbonyl function of the substrate acetyl-L-lysine residue coordinates to the Zn2+ ion [28,43] and subsequently accepts a hydrogen bond from the catalytic tyrosine residue (Tyr306) in the precatalytic human HDAC-8 enzyme (Figure 3) and the substrate complex [40,41].”
Loop Interactions and Dynamics Tune the Enzymatic Activity of the Human Histone Deacetylase 8
Kunze, M. B. A., Wright, D. W., Werbeck, N. D., Kirkpatrick, J., Coveney, P. V., & Hansen, D. F. (2013) · Journal of the American Chemical Society · doi:10.1021/ja408184x · Cited by 41
A distal regulatory region of a class I human histone deacetylase
Werbeck, N. D., Shukla, V. K., Kunze, M. B. A., Yalinca, H., Pritchard, R. B., Siemons, L., Mondal, S., Greenwood, S. O. R., Kirkpatrick, J., Marson, C. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17610-w · Cited by 40
Ortore, G., Colo, F. D., & Martinelli, A. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900288e · Cited by 40
Werbeck, N. D., Kirkpatrick, J., & Hansen, D. F. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209385 · Cited by 38
Prestegui-Martel, B., Bermúdez-Lugo, J. A., Chávez-Blanco, A. D., Dueñas‐González, A., García-Sánchez, J. R., Pérez-González, O. A., Martínez, I. I. P., Fragoso-Vázquez, M. J., Mendieta‐Wejebe, J. E., Correa-Basurto, A. M., et al. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1210138 · Cited by 43
Deardorff, M. A., Porter, N. J., & Christianson, D. W. (2016) · Protein Science · doi:10.1002/pro.3030 · Cited by 37
“enable crystallization with an unreacted substrate).(36,39) These interactions orient and polarize”
BackgroundCastañeda, C. A., Wolfson, N. A., Leng, K. R., Kuo, Y.-M., Andrews, A. J., & Fierke, C. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.811026 · Cited by 38
“Until now, HDAC recognition of protein substrates has largely been tackled by studying activity toward peptide substrates, which typically interact with less than an 8 20-Å(2) area of an 2,025-Å(2) binding surface (22).”
BackgroundOne-Atom Substitution Enables Direct and Continuous Monitoring of Histone Deacylase Activity
Zessin, M., Kutil, Z., Meleshin, M., Nováková, Z., Ghazy, E., Kalbas, D., Marek, M., Romier, C., Sippl, W., Bařinka, C., et al. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00786 · Cited by 37
Haider, S., Joseph, C. G., Neidle, S., Fierke, C. A., & Fuchter, M. J. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.128 · Cited by 39
Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components
Wheatley, N. C., Andrews, K. T., Tran, T. L., Lucke, A. J., Reid, R. C., & Fairlie, D. P. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.096 · Cited by 38
Metal-dependent Deacetylases: Cancer and Epigenetic Regulators
López, J. E., Sullivan, E. D., & Fierke, C. A. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b01067 · Cited by 37
Kutil, Z., Skultetyova, L., Rauh, D., Meleshin, M., Šnajdr, I., Nováková, Z., Mikesova, J., Pavlíček, J., Hadzima, M., Baranová, P., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201801680r · Cited by 39
“Although in HDAC8, highly conserved Asp101 accepts hydrogen bonds from both backbone amides flanking the acetyllysine, in HDAC6, the backbone amide following acetyllysine is hydrogen bonded only to a water molecule, allowing at least in principle the accommodation of proline at this position (39, 40).”
BackgroundStructural analyses of inositol phosphate second messengers bound to signaling effector proteins
Blind, R. D. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2019.100667 · Cited by 38
“There is no evidence HDACs other than Class 1 are regulated by inositols, and while HDAC8 is considered a Class 1 HDAC no inositol was found in the crystal structure of HDAC8 (Vannini et al., 2007).”
BackgroundInfluentialBermúdez-Lugo, J. A., Pérez-González, O. A., Rosales‐Hernández, M. C., Ilizaliturri‐Flores, I., Trujillo-Ferrara, J. G., & Correa‐Basurto, J. (2011) · Journal of Molecular Modeling · doi:10.1007/s00894-011-1240-z · Cited by 36
“To use all of the 3-D structures of HDAC attained from the experimental methods, a search of the PDB was performed, which found 14 structures that belonged to isoform 8 (PDB codes: 1T64 [20], 1T67 [20], 1T69 [20], 1VKG [20], 1W22 [21], 2V5W [22], 2V5X [22], 3EW8 [22], 3EWF [23], 3EZP [23], 3EZT [23], 3F0R [23], 3F06 […”
MethodLall, S. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1107-1110 · Cited by 38
Linarès, A., Dalenc, F., Balaguer, P., Boulle, N., & Cavaillès, V. (2010) · BioMed Research International · doi:10.1155/2011/856985 · Cited by 36
Mechanistic and Structural Understanding of Uncompetitive Inhibitors of Caspase-6
Heise, C. E., Murray, J. M., Augustyn, K. E., Bravo, B. J., Chugha, P., Cohen, F., Giannetti, A. M., Gibbons, P., Hannoush, R. N., Hearn, B. R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050864 · Cited by 39
The Natural Tumor Suppressor Protein Maspin and Potential Application in Non Small Cell Lung Cancer
Lonardo, F., Li, X., Kaplun, A., Soubani, A. O., Sethi, S. N., Gadgeel, S. M., & Sheng, S. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791208974 · Cited by 34
“The overall catalytic domain of HDAC1 is similar to that of a protease such as serine protease or metalloproteinase [34,35].”
BackgroundAlam, N., & Schueler‐Furman, O. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6798-8_9 · Cited by 35
Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases
Christianson, D. W. (2024) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00801 · Cited by 37
Porter, N. J., Christianson, N. H., Decroos, C., & Christianson, D. W. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b01014 · Cited by 33
Porter, N. J., Shen, S., Barinka, C., Kozikowski, A. P., & Christianson, D. W. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00487 · Cited by 30
Progress towards water-soluble triazole-based selective MMP-2 inhibitors
Fabre, B., Filipiak, K., Zapico, J. M., Díaz, N., Carbajo, R. J., Schott, A. K., Martinez‐Alcazar, M. P., Suárez, D., Pineda‐Lucena, A., Ramos, A., et al. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob41046c · Cited by 32
Amin, S. A., Khatun, S., Gayen, S., Das, S., & Jha, T. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115594 · Cited by 34
Ilies, M., Dowling, D., Lombardi, P. M., & Christianson, D. W. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.100 · Cited by 31
Liu, J., Zhu, Y., He, Y., Zhu, H., Gao, Y. Q., Li, Z., Zhu, J., Sun, X., Fang, F., Wen, H., et al. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1590241 · Cited by 30
“In addition to these hydrogen bonding interactions, TSA also showed strong p–p interactions with Tyr100 and Phe208, which might facilitate ligands to orient themselves through the hydrophobic channel over to the catalytic region (Vannini et al., 2007).”
BackgroundArrar, M., Turnham, R., Pierce, L., de Oliveira, C. A. F., & McCammon, J. A. (2013) · Protein Science · doi:10.1002/pro.2190 · Cited by 30
Molecular Modeling Study on Tunnel Behavior in Different Histone Deacetylase Isoforms
Thangapandian, S., John, S., Lee, Y., Arulalapperumal, V., & Lee, K. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049327 · Cited by 30
Intrinsic structural dynamics dictate enzymatic activity and inhibition
Shukla, V. K., Siemons, L., & Hansen, D. F. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2310910120 · Cited by 29
“The human HDAC8 construct described by Vannini et al. (39) with a C - terminal hexa - histidine tag in pET21b expression vector was used to express the protein in BL21( λ DE3) cells.”
BackgroundMethodPhotochromic histone deacetylase inhibitors based on dithienylethenes and fulgimides
Wutz, D., Gluhacevic, D., Chakrabarti, A., Schmidtkunz, K., Robaa, D., Erdmann, F., Romier, C., Sippl, W., Jung, M., & König, B. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob00976c · Cited by 31
Structural Biology of Human Metal-Dependent Histone Deacetylases
Schapira, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_10 · Cited by 33
“2008) and HDAC8 (Dowling et al. 2008; Dowling et al. ; Somoza et al. 2004; Vannini et al. 2004; Vannini et al. 2007) solved since confirmed the general architecture revealed by the seminal work on the bacterial enzyme, and define a set of canonical features (Figure 2): (1) a funnel-shaped lysine binding channel locate…”
BackgroundInfluentialOnonye, S. N., Heyst, M. D. V., Falcone, E. R., Anderson, A. C., & Wright, D. L. (2012) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.12.21 · Cited by 31
Karunanithy, G., Shukla, V. K., & Hansen, D. F. (2024) · Nature Communications · doi:10.1038/s41467-024-49378-8 · Cited by 26
“The Human HDAC8 construct described by Vannini et al. with a C-terminal 6X-histidine tag in ampicillin-resistant pET21b expression vector was transformed in BL21( λ DE3) E. coli cells for protein expression 20,39 .”
Song, Y. J., Lu, H., Xu, J., Wang, X., Zhou, W., Hou, L., Zhu, L., Yu, Z., Chen, H., & Cui, Y. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.12.002 · Cited by 26
Sixto‐López, Y., Gómez-Vidal, J. A., & Correa‐Basurto, J. (2014) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-014-0976-1 · Cited by 26
Design and synthesis of novel dual-target agents for HDAC1 and CK2 inhibition
Purwin, M., Hernández-Toribio, J., Coderch, C., Panchuk, R. R., Skorokhyd, N. R., Filipiak, K., de Pascual‐Teresa, B., & Ramos, A. (2016) · RSC Advances · doi:10.1039/c6ra09717k · Cited by 26
Histone Deacetylase 8: Characterization of Physiological Divalent Metal Catalysis
Nechay, M. R., Gallup, N. M., Morgenstern, A., Smith, Q. A., Eberhart, M. E., & Alexandrova, A. N. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b00997 · Cited by 32
X-ray Crystallographic Snapshots of Substrate Binding in the Active Site of Histone Deacetylase 10
Herbst‐Gervasoni, C. J., & Christianson, D. W. (2021) · Biochemistry · doi:10.1021/acs.biochem.0c00936 · Cited by 22
Khatun, S., Bhagat, R. P., Amin, S. A., Jha, T., & Gayen, S. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108468 · Cited by 30
An enzyme-coupled assay measuring acetate production for profiling histone deacetylase specificity
Wolfson, N. A., Pitcairn, C. A., Sullivan, E. D., Joseph, C. G., & Fierke, C. A. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.03.012 · Cited by 22
“Crystal structures of a methylcoumarin-conjugated peptide bound to HDAC8 visualize interactions between the methylcoumarin and the side chain of Tyr100 [13,38].”
BackgroundUsing 15 N‐Ammonium to Characterise and Map Potassium Binding Sites in Proteins by NMR Spectroscopy
Werbeck, N. D., Kirkpatrick, J., Reinstein, J., & Hansen, D. F. (2014) · ChemBioChem · doi:10.1002/cbic.201300700 · Cited by 23
A Genetically Encoded, Phage‐Displayed Cyclic‐Peptide Library
Wang, X. S., Chen, P. C., Hampton, J. T., Tharp, J. M., Reed, C. A., Das, S. K., Wang, D., Hayatshahi, H. S., Shen, Y., Liu, J., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201908713 · Cited by 26
Herp, D., Ridinger, J., Robaa, D., Shinsky, S. A., Schmidtkunz, K., Yesiloglu, T. Z., Bayer, T., Steimbach, R. R., Herbst‐Gervasoni, C. J., Merz, A., et al. (2022) · ChemBioChem · doi:10.1002/cbic.202200180 · Cited by 22
Evidence that HDAC7 acts as an epigenetic “reader” of AR acetylation through NCoR-HDAC3 dissociation
Zhang, Y., Andrade, R. E., Hanna, A. A., & Pflum, M. K. H. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.05.008 · Cited by 23
Gong, W., Wu, R., & Zhang, Y. (2015) · Journal of Computational Chemistry · doi:10.1002/jcc.24203 · Cited by 24
Cao, G. P., Arooj, M., Thangapandian, S., Park, C., Arulalapperumal, V., Kim, Y., Kwon, Y. J., Kim, H. H., Suh, J.-K., & Lee, K. W. (2015) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2015.1040453 · Cited by 22
“Protein was coordinated from the crystal structure of HDAC8 (PDB ID: 2V5X) [9], which was selected from the Protein Data Bank (PDB, www.”
BackgroundMethodFeng, T., Wang, H., Su, H. L., Lu, H., Yu, L., Zhang, X., Sun, H., & You, Q. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.06.009 · Cited by 23
Structure of Arabidopsis HISTONE DEACETYLASE15
Chen, C., Tu, Y., Hsu, J.-C., Hung, H.-C., Liu, T.-C., Lee, Y., Chou, C., Cheng, Y., & Wu, K. (2020) · PLANT PHYSIOLOGY · doi:10.1104/pp.20.00604 · Cited by 19
Tang, C. C., Du, Y., Liang, Q. Y., Cheng, Z., & Tian, J. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00383e · Cited by 21
Insights from comprehensive multiple receptor docking to HDAC8
Brunsteiner, M., & Petukhov, P. A. (2012) · Journal of Molecular Modeling · doi:10.1007/s00894-011-1297-8 · Cited by 22
Lactylation in cancer: molecular mechanisms and advances in clinical study
Li, J., Miao, C., Guo, H., Lin, M., Chen, R., Peng, J., Wang, J., Tang, C., & Chen, Z. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02573-1 · Cited by 31
“Modeling indicates the pocket can accommodate ε-N-lactyllysine (slightly larger than acetyl and bearing an α-hydroxyl) without major rearrangements [59, 63].”
Vorinostat-Like Molecules as Structural, Stereochemical, and Pharmacological Tools
Hanessian, S., Auzzas, L., Larsson, A., Zhang, J., Giannini, G., Gallo, G., Ciacci, A., & Cabri, W. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100028g · Cited by 20
Hirsch, B. M., Du, Z., Li, X., Sylvester, J. A., Wesdemiotis, C., Wang, Z., & Zheng, W. (2011) · MedChemComm · doi:10.1039/c0md00212g · Cited by 18
Bai, M., Cui, M., Li, M., Yao, X., Wu, Y., Zheng, L., Sun, L., Song, Q., Wang, S., Liu, L., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.62339 · Cited by 18
“The body has better adaptability when entering its active center [27-29], which makes HDAC8 a good choice for computer-assisted drug screening.”
BackgroundKinetics and thermodynamics of metal‐binding to histone deacetylase 8
Kim, B.-C., Pithadia, A. S., & Fierke, C. A. (2015) · Protein Science · doi:10.1002/pro.2623 · Cited by 21
Zhou, J., Xie, H., Liu, Z., Luo, H., & Wu, R. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500513n · Cited by 18
Inhibition mechanism of SAHA in HDAC: a revisit
Zhou, J., Wu, R., & Luo, H. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp05633k · Cited by 18
Greenwood, S. O. R., Chan, A. W. E., Hansen, D. F., & Marson, C. M. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126926 · Cited by 16
Ligand release mechanisms and channels in histone deacetylases
Kalyaanamoorthy, S., & Chen, Y. P. (2013) · Journal of Computational Chemistry · doi:10.1002/jcc.23390 · Cited by 15
Singh, P., Suzuki, T., Mandal, T., Balsubramanian, N., Haldar, M., Mueller, D. J., Strode, J. A., Cook, G. R., Mallik, S., & Srivastava, D. K. (2014) · Biochemistry · doi:10.1021/bi500711x · Cited by 16
Castañeda, C. A., López, J. E., Joseph, C. G., Scholle, M. D., Mrksich, M., & Fierke, C. A. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00851 · Cited by 15
Varga, J. K., Diffley, K., Leng, K. W., Fierke, C. A., & Schueler‐Furman, O. (2022) · Scientific Reports · doi:10.1038/s41598-022-05681-2 · Cited by 17
“Comparison of the KDAC6 (PDB ID: 5EFN [5]) and KDAC8 (PDB ID: 2V5W [68] structures (Figure 2) highlight two main differences in loops involved in forming the binding pocket that could lead to differences in binding selectivity.”
BackgroundQSAR modeling to design selective histone deacetylase 8 (HDAC8) inhibitors
Cao, G. P., Thangapandian, S., Son, M., Kumar, R., Choi, Y. J., Kim, Y., Kwon, Y. J., Kim, H.-H., Suh, J.-K., & Lee, K. W. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0705-5 · Cited by 15
“Except HDAC8, functional HDACs are found as multimeric complexes of high molecular weight and most of them are functionally inactive (Vannini et al. 2007; Bolden et al. 2006).”
BackgroundMethodInfluentialDewaker, V., Srivastava, P. N., Verma, S. K., & Prabhakar, Y. S. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1598497 · Cited by 14
“This (S39D) was introduced in the protein to improve its crystallization (Decroos et al., 2015; Vannini et al., 2007).”
BackgroundMethodInfluentialPrejanò, M., Vidossich, P., Russo, N., Vivo, M. D., & Marino, T. (2021) · ACS Catalysis · doi:10.1021/acscatal.0c04729 · Cited by 15
Lu, H., Chen, Y., Yang, B., & You, Q. (2011) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2011.10.002 · Cited by 14
“Condensation of 3-(hydroxymethyl)pyridine or substituted phenyl methanol (1) with 4-(aminomethyl)benzoic acid (3) using 1,10-carbonyldiimidazole (2) gave carboxylic acids 4, which underwent an amide coupling reaction with 2,5dimethoxyaniline to afford 5.”
MethodNovel HDAC8 inhibitors: A multi-computational approach
Manal, M., Manish, K. K., Sanal, D., Ayyamperumal, S., Devadasan, V., & Chandrasekar, M. (2017) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2017.1375978 · Cited by 14
“This is in concurrence with earlier reports [12, 41, 42] indicating that the projected binding of the ligands to these residues of HDAC8 may prove beneficial in enzyme inhibition.”
BackgroundResultIntrinsic Dynamics of the Binding Rail and Its Allosteric Effect in the Class I Histone Deacetylases
Zhou, J., Huang, Y., Cheng, C., Wang, K., & Wu, R. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00251 · Cited by 13
Yang, Y., Hu, B., Yang, Y., Gong, K., Wang, H., Guo, Q., Tang, X., Li, Y., & Wang, J. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp02264d · Cited by 12
González, F. P. G., & Mancilla, T. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104080 · Cited by 13
Deshpande, S. H., Bagewadi, Z. K., Khan, T. M. Y., Mahnashi, M. H., Shaikh, I. A., Alshehery, S., Khan, A. A., Patil, V. S., & Roy, S. (2023) · Molecules · doi:10.3390/molecules28062430 · Cited by 12
“The key structural configuration of HDAC8 consists of a specific domain (region) ranging from 14–324 amino acids, which defines it as histone deacetylase enzyme [10], with an active site in 143rd position, and two types of binding sites: a divalent metal cation binding site in 178th, 180th and 267th position [11]; and…”
BackgroundHydroxamates of para-aminobenzoic acid as selective inhibitors of HDAC8
Kulandaivelu, U., Chilakamari, L. M., Jadav, S. S., Rao, T. R., Jayaveera, K. N., Boyapati, S., Hauser, A., Senger, J., Marek, M., Romier, C., et al. (2014) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2014.08.005 · Cited by 13
Abdelkarim, H., Neelarapu, R., Madriaga, A., Vaidya, A. S., Kastrati, I., Karumudi, B., Wang, Y., Taha, T. Y., Thatcher, G. R. J., Frasor, J. M., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700449 · Cited by 14
Leng, K. W., Castañeda, C. A., Decroos, C., Islam, B., Haider, S. M., Christianson, D. W., & Fierke, C. A. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00653 · Cited by 13
“The conformational change of D29 resulting from the S39E substitution is not observed in S39D HDAC8; D29 remains in its wild-type conformation in this mutant (Figure S2).(26) The D29-”
InfluentialRational Design and Development of HDAC Inhibitors for Breast Cancer Treatment
Mody, D., Bouckaert, J. M. J., Savvides, S. N., & Gupta, V. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210917143953 · Cited by 13
“25 Å) A, B (388 aa) -- V5X (A, B) - ZN (A, B) - K (A, B) 2V5W (31)*”
Garsi, J.-B., Sernissi, L., Vece, V., Hanessian, S., McCracken, A. N., Simitian, G. S., & Edinger, A. L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.043 · Cited by 13
Optimization of a series of potent and selective ketone histone deacetylase inhibitors
Pescatore, G., Kinzel, O. D., Attenni, B., Cecchetti, O., Fiore, F., Fonsi, M., Rowley, M., Schultz‐Fademrecht, C., Serafini, S., Steinkühler, C., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.09.003 · Cited by 12
Self-citationShukla, V. K., Siemons, L., Gervasio, F. L., & Hansen, D. F. (2021) · Chemical Science · doi:10.1039/d1sc01929e · Cited by 12
Khatun, S., Dasgupta, I., Islam, R., Amin, S. A., Jha, T., Dhaked, D. K., & Gayen, S. (2024) · Molecular Diversity · doi:10.1007/s11030-024-10903-y · Cited by 10
“HDACs are categorized into four groups based on phylogenetic relationships, with Class III acting as a nicotina-mide-adenine dinucleotide-dependent lysine deacetylase, while Classes I, II, and IV are zinc-dependent [7, 9, 10].”
Binding mechanism and distant regulation of histone deacetylase 8 by PCI-34051
Luo, Y., Yan, Z., Chu, X., Zhang, Y., Qiu, Y., & Li, H. (2025) · Communications Biology · doi:10.1038/s42003-025-07649-0 · Cited by 11
“AlthoughtheY100-D101ofL2-Awasreportedto beinteractedwiththesubstrateinVannini ’ s early investigation 66 .”
Werbeck, N. D., Kirkpatrick, J., & Hansen, D. F. (2013) · Angewandte Chemie · doi:10.1002/ange.201209385 · Cited by 10
Ward, B. H., Prasai, K., Schaal, D. L., Wang, J., & Scott, R. S. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011873 · Cited by 10
Debnath, S., Debnath, T., Majumdar, S., Arunasree, M. K., & Vema, A. (2016) · Medicinal Chemistry Research · doi:10.1007/s00044-016-1652-5 · Cited by 11
“30 Å) were retrieved from RCSB protein data bank for present studies (Somoza et al., 2004; Vannini et al., 2007; Whitehead et al., 2011; Dowling et al., 2008).”
MethodOsko, J. D., Porter, N. J., Decroos, C., Lee, M. S., Watson, P. R., Raible, S. E., Krantz, I. D., Deardorff, M. A., & Christianson, D. W. (2020) · Journal of Structural Biology · doi:10.1016/j.jsb.2020.107681 · Cited by 11
“There are no major conformational differences between the structures of the E66D/Y306F HDAC8–Ac-RHKAcKAc-AMC complex and the previously reported Y306F HDAC8–Ac-RHKAcKAc-AMC complex (PDB 2V5W) (Vannini et al., 2007), and the rmsd is 0.”
BackgroundLactylation in tumor: mechanisms and therapeutic potentials
Wang, D., Rong, H., Ma, K., & Peng, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1609596 · Cited by 14
Moinul, M., Amin, S. A., Khatun, S., Das, S., Jha, T., & Gayen, S. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.133967 · Cited by 10
Environment-sensitive fluorescent inhibitors of histone deacetylase
Zhou, X., Dong, G., Song, T.-J., Wang, G., Li, Z., Qin, X., Du, L., & Li, M. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127128 · Cited by 9
Novel Folate-Hydroxamate Based Antimetabolites: Synthesis and Biological Evaluation
Carrasco, M. P., Enyedy, É. A., Krupenko, N. I., Krupenko, S. A., Nuti, E., Tuccinardi, T., Santamaria, S., Rossello, A., Martinelli, A., & Santos, M. A. (2011) · Medicinal Chemistry · doi:10.2174/157340611796150923 · Cited by 9
Wang, J., Cao, Z., Wang, F., Wang, P., An, J., Fu, X., Liu, T., Li, Y., Li, Y., Zhao, Y., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113799 · Cited by 8
Kim, G. S., Jung, H.-E., Kim, J., & Lee, Y. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132680 · Cited by 10
“The crystal structure of HDAC8 bound with acetylated peptide substrate revealed that the residues (His142, His143, Asp176, Asp183 and Tyr306) around the catalytic cavity interact with one water molecule and zinc ion [37].”
BackgroundThe Chemical Tuning of a Weak Zinc Binding Motif for Histone Deacetylase Using Electronic Effects
McCarren, P. R., Hall, M. L., & Whitehead, L. (2012) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2012.01382.x · Cited by 8
Regulation of Histone Deacetylase Activities and Functions by Phosphorylation and Dephosphorylation
Seto, E., & Yang, X. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00286-2 · Cited by 10
Design and evaluation of nanoscale materials with programmed responsivity towards epigenetic enzymes
Ray, P., Sedigh, A., Confeld, M. I., Alhalhooly, L., Iduoku, K., Casañola‐Martín, G. M., Pham‐The, H., Rasulev, B., Choi, Y., Yang, Z., et al. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00514g · Cited by 8
Herbel, S. M., Moyon, L., Christ, M., Elsayed, E., Caffrey, B. E., Malmsheimer, S., Grin, I., Hoffmann, K., Surmann, K., Blankenburg, S., et al. (2022) · Virulence · doi:10.1080/21505594.2022.2149973 · Cited by 7
“From querying the UniProtKB with the Pfam ID PF00850 (“histone-deacetylase” domain), we selected two eukaryotic protein sequences: the human Histone-deacetylase 3 (HDAC3, NCBI protein ID NP_003874), as well as a putative “histone-deacetylase 1” protein (NCBI protein ID: XP_004368317) from A. castellanii strain Neff.”
BackgroundInfluentialBiological activities of substituted trichostatic acid derivatives
Charrier, C., Roche, J., Gesson, J., & Bertrand, P. (2009) · Journal of Chemical Sciences · doi:10.1007/s12039-009-0056-1 · Cited by 7
Metadata
- Authors
- Vannini, A., Volpari, C., Gallinari, P., Jones, P., Mattu, M., Carfí, A., De Francesco, R., Steinkühler, C., & Di Marco, S.
- Affiliations
- Institute of Molecular Biology and Pathology (IT)
- Venue
- The EMBO Reports
- Published
- 2007-08-10
- Volume
- 8
- Issue
- 9
- Pages
- 879-884
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC1973954
- OpenAlex
- W2164806419
- Cited by
- 256
- References
- 27
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 12 · 2020: 13 · 2019: 16 · 2018: 14 · 2017: 18 · 2016: 21 · 2015: 14 · 2014: 16 · 2013: 16 · 2012: 17
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
- Keywords
- HDAC8, substrate binding, active site residues, hydroxamate inhibitors, substrate recognition, catalytically inactive mutant, histone deacetylase inhibitors
- MeSH terms
- Aspartic Acid, Enzyme Inhibitors, Histone Deacetylases, Humans, Models, Molecular, Repressor Proteins, Structure-Activity Relationship, Substrate Specificity, Protein Structure, Secondary, Crystallography, X-Ray
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.